A20 overexpression inhibits lipopolysaccharide-induced NF-κB activation, TRAF6 and CD40 expression in rat peritoneal mesothelial cells

International Journal of Molecular Sciences

Volumn 15, Issue 4, 2014, Pages 6592-6608

  Zou, Xun Liang ^a   Pei, De An ^b   Yan, Ju Zhen ^a   Xu, Gang ^a   Wu, Ping ^a  

^a HANGZHOU NORMAL UNIVERSITY   (China)

^b Red Cross Hospital of Hangzhou   (China)

Author keywords

CD40; NF B; Rat peritoneal mesothelial cells; TRAF6; Zinc finger protein A20

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN A20; CD40 ANTIGEN; DNA BINDING PROTEIN; I KAPPA B; NF-KAPPAB INHIBITOR ALPHA; NUCLEAR PROTEIN; SIGNAL PEPTIDE; TNFAIP3 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL VIABILITY; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DNA BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL PERITONITIS; GENE OVEREXPRESSION; GENETIC TRANSFECTION; INFLAMMATION; MESOTHELIUM CELL; NONHUMAN; PERITONEUM CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECTS; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PERITONEUM; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; TOXICITY;

ANIMALS; ANTIGENS, CD40; CELL SURVIVAL; CELLS, CULTURED; DNA-BINDING PROTEINS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; I-KAPPA B PROTEINS; INTERLEUKIN-6; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOPOLYSACCHARIDES; MALE; NF-KAPPA B; NUCLEAR PROTEINS; PERITONEUM; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 6;

EID: 84899142909     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15046592     Document Type: Article

References (41)

1. Krediet, R.T. 30 years of peritoneal dialysis development: The past and the future. Perit. Dial. Int. 2007, 27, S35-S41.
2. Gokal, R. Peritoneal dialysis in the 21st century: An analysis of current problems and future developments. J. Am. Soc. Nephrol. 2002, 13, S104-S116.
3. Szeto, C.C.; Chow, K.M. Gram-negative peritonitis-The Achilles heel of peritoneal dialysis? Perit. Dial. Int. 2007, 27, S267-S271.
4. Devuyst, O.; Margetts, P.J.; Topley, N. The pathophysiology of the peritoneal membrane. J. Am. Soc. Nephrol. 2010, 21, 1077-1085.
5. Park, J.H.; Kim, Y.G.; Shaw, M.; Kanneganti, T.D.; Fujimoto, Y.; Fukase, K.; Inohara, N.; Núñez, G. Nod1/RICK and TLR signaling regulate chemokine and antimicrobial innate immune responses in mesothelial cells. J. Immunol. 2007, 179, 514-521.
6. Kato, S.; Yuzawa, Y.; Tsuboi, N.; Maruyama, S.; Morita, Y.; Matsuguchi, T.; Matsuo, S. Endotoxin-induced chemokine expression in murine peritoneal mesothelial cells: The role of toll-like receptor4. J. Am. Soc. Nephrol. 2004, 15, 1289-1299.
7. Kawagoe, T.; Sato, S.; Matsushita, K.; Kato, H.; Matsui, K.; Kumagai, Y.; Saitoh, T.; Kawai, T.; Takeuchi, O.; Akira, S. Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK 2. Nat. Immunol. 2008, 9, 684-691.
8. O'Neill, L.A. When signaling pathways collide: Positive and negative regulation of Toll-like receptor signal transduction. Immunity 2008, 29, 12-20.
9. Li, X. IRAK4 in TLR/IL-1R signaling: Possible clinical applications. Eur. J. Immunol. 2008, 38, 614-618.
10. Hayden, M.S.; Ghosh, S. Shared principles in NF-κB signaling. Cell 2008, 132, 344-362.
11. Lomaga, M.A.; Yeh, W.C.; Sarosi, I.; Duncan, G.S.; Furlonger, C.; Ho, A.; Morony, S.; Capparelli, C.; Van, G.; Kaufman, S. et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 1999, 13, 1015-1024.
12. Laman, J.D.; de Boer, M.; Hart, B.A. CD40 in clinical inflammation: From multiple sclerosis to atherosclerosis. Dev. Immunol. 1998, 6, 215-222.
13. Zhang, Y.F.; Yang, X.; Zhang, Y.J.; Sun, Y.L.; Zou, X.L.; Kong, Q.Y.; Dong, X.Q.; Ye, X.Q.; Yu, X.Q. Peroxisome proliferator-activated receptor-gamma is expressed by rat peritoneal mesothelial cells: Its potential role in peritoneal cavity local defense. Am. J. Nephrol. 2006, 26, 602-611.
14. Wu, J.; Yang, X.; Zhang, Y.F.; Zhou, S.F.; Zhang, R.; Dong, X.Q.; Fan, J.J.; Liu, M.; Yu, X.Q. Angiotensin II upregulates Toll-like receptor 4 and enhances lipopolysaccharide-induced CD40 expression in rat peritoneal mesothelial cells. Inflamm. Res. 2009, 58, 473-482.
15. Rowland, S.L.; Tremblay, M.M.; Ellison, J.M.; Stunz, L.L.; Bishop, G.A.; Hostager, B.S. A novel mechanism for TNFR-associated factor 6-dependent CD40 signaling. J. Immunol. 2007, 179, 4645-4653.
16. Vereecke, L.; Beyaert, R.; van Loo, G. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. Trends Immunol. 2009, 30, 383-391.
17. Coornaert, B.; Carpentier, I.; Beyaert, R. A20: Central gatekeeper in inflammation and immunity. J. Biol. Chem. 2009, 284, 8217-8221.
18. Lee, E.G.; Boone, D.L.; Chai, S.; Libby, S.L.; Chien, M.; Lodolce, J.P.; Ma, A. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 2000, 289, 2350-2354.
19. Kang, N.I.; Yoon, H.Y.; Lee, Y.R.; Won, M.; Chung, M.J.; Park, J.W.; Hur, G.M.; Lee, H.K.; Park, B.H. A20 attenuates allergic airway inflammation in mice. J. Immunol. 2009, 183, 1488-1495.
20. Hah, Y.S.; Lee, Y.R.; Jun, J.S.; Lim, H.S.; Kim, H.O.; Jeong, Y.G.; Hur, G.M.; Lee, S.Y.; Chung, M.J.; Park, J. W. et al. A20 suppresses inflammatory responses and bone destruction in human fibroblast-like synoviocytes and in mice with collagen-induced arthritis. Arthritis Rheum. 2010, 62, 2313-2321.
21. Gui, J.; Yue, Y.; Chen, R.; Xu, W.; Xiong, S. A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting NF-κB signaling. PLoS One 2012, 7, e46515.
22. Loniewski, K.J.; Patial, S.; Parameswaran, N. Sensitivity of TLR4- and -7-induced NFkappa B1 p105-TPL2-ERK pathway to TNF-receptor-associated-factor-6 revealed by RNAi in mouse macrophages. Mol. Immunol. 2007, 44, 3715-3723.
23. Oshima, N.; Ishihara, S.; Rumi, M.A.; Aziz, M.M.; Mishima, Y.; Kadota, C.; Moriyama, I.; Ishimura, N.; Amano, Y.; Kinoshita, Y. A20 is an early responding negative regulator of Toll-like receptor 5 signalling in intestinal epithelial cells during inflammation. Clin. Exp. Immunol. 2010, 159, 185-198.
24. Turer, E.E.; Tavares, R.M.; Mortier, E.; Hitotsumatsu, O.; Advincula, R.; Lee, B.; Shifrin, N.; Malynn, B.A.; Ma, A. Homeostatic MyD88 dependent signals cause lethal inflammation in the absence of A20. J. Exp. Med. 2008, 205, 451-464.
25. Werner, S.L.; Kearns, J.D.; Zadorozhnaya, V.; Lynch, C.; O'Dea, E.; Boldin, M.P.; Ma, A.; Baltimore, D.; Hoffmann, A. Encoding NF-kappaB temporal control in response to TNF: Distinct roles for the negative regulators IkappaBalpha and A 20. Genes Dev. 2008, 22, 2093-2101.
26. Xiong, Y.; Qiu, F.; Piao, W.; Song, C.; Wahl, L.M.; Medvedev, A.E. Endotoxin tolerance impairs IL-1 receptor-associated kinase (IRAK) 4 and TGF-beta-activated kinase 1 activation, K63-linked polyubiquitination and assembly of IRAK1, TNF receptor-associated factor 6, and IkappaB kinasegamma and increases A20 expression. J. Biol. Chem. 2011, 286, 7905-7916.
27. Chen, Z. J. Ubiquitin signalling in the NF-kappaB pathway. Nat. Cell Biol. 2005, 7, 758-765.
28. Jakus, P.B.; Kalman, N.; Antus, C.; Radnai, B.; Tucsek, Z.; Gallyas, F.; Sumegi, B., Jr.; Veres, B. TRAF6 is functional in inhibition of TLR4-mediated NF-κB activation by resveratrol. J. Nutr. Biochem. 2013, 24, 819-823.
29. Mabilleau, G.; Chappard, D.; Sabokbar, A. Role of the A20-TRAF6 axis in lipopolysaccharide-mediated osteoclastogenesis. J. Biol. Chem. 2011, 286, 3242-3249.
30. Shi, C.S.; Kehrl, J.H. Traf6 and A20 differentially regulate TLR4-induced autophagy by affecting the ubiquitination of Beclin 1. Autophagy 2010, 6, 986-987.
31. Komander, D.; Barford, D. Structure of the A20 OTU domain and mechanistic insights into deubiquitination. Biochem. J. 2008, 409, 77-85.
32. Lin, S.C.; Chung, J.Y.; Lamothe, B.; Rajashankar, K.; Lu, M.; Lo, Y.C.; Lam, A.Y.; Darnay, B.G.; Wu, H. Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20. J. Mol. Biol. 2008, 376, 526-540.
33. Iha, H.; Peloponese, J.M.; Verstrepen, L.; Zapart, G.; Ikeda, F.; Smith, C.D.; Starost, M.F.; Yedavalli, V.; Heyninck, K.; Dikic, I. et al. Inflammatory cardiac valvulitis in TAX1BP1-deficient mice through selective NF-kappaB activation. EMBO J. 2008, 27, 629-641.
34. Glik, A.; Mazar, J.; Rogachev, B.; Zlotnik, M.; Douvdevani, A. CD40 ligand expression correlates with resolution of peritonitis and mononuclear cell recruitment. Perit. Dial. Int. 2005, 25, 240-247.
35. Tavares, R.M.; Turer, E.E.; Liu, C.L.; Advincula, R.; Scapini, P.; Rhee, L.; Barrera, J.; Lowell, C.A.; Utz, P.J.; Malynn, B.A.; et al. The ubiquitin modifying enayme A20 restricts B cell survival and prevents autoimmunity. Immunity 2010, 33, 181-191.
36. Wajant, H.; Henkler, F.; Scheurich, P. The TNF-receptor-associated factor family: Scaffold mole-cules for cytokine receptors, kinases and theirregulators. Cell Signal. 2001, 13, 389-400.
37. Aggarwal, B.B. Signalling pathways of the TNF superfamily: A double-edged sword. Nat. Rev. Immunol. 2003, 3, 745-756.
38. Chung, J.Y.; Park, Y.C.; Ye, H.; Wu, H. All TRAFs are not created equal: Common and distinct molecular mechanisms of TRAF-mediated signal transduction. J. Cell Sci. 2002, 115, 679-688.
39. Bishop, G.A.; Hostager, B.S.; Brown, K.D. Mechanisms of TNF receptor-associated factor (TRAF) regulation in B lymphocytes. J. Leukoc. Biol. 2002, 72, 19-23.
40. Ishida, T.; Mizushima, S.; Azuma, S.; Kobayashi, N.; Tojo, T.; Suzuki, K.; Aizawa, S.; Watanabe, T.; Mosialos, G.; Kieff, E. et al. Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J. Biol. Chem. 1996, 271, 28745-28748.
41. Qin, H.; Wilson, C.A.; Lee, S.J.; Zhao, X.; Benveniste, E.N. LPS induces CD40 gene expression through the activation of NF-kappaB and STAT-1alpha in macrophages and microglia. Blood 2005, 106, 3114-3122.